Susan D. Reed

ORCID: 0000-0001-7532-3785 · 8 papers in corpus
nonrandomized-trial 2022
Obstetrics and gynecology ·doi:10.1097/aog.0000000000005000

OBJECTIVE: To explore to what extent intrauterine device (IUD) expulsion is associated with demographic and clinical risk factors. METHODS: The APEX-IUD (Association of Perforation and Expulsion of IntraUterine Devices) study was a U.S. co…

observational 2021
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2021.06.067

BACKGROUND: Accurate estimates of incidence and prevalence of endometriosis among nonselected cohorts are lacking in the United States, and earlier reports have produced varying results. OBJECTIVE: This study aimed to define endometriosis …

observational 2021
·doi:10.1097/01.ogx.0000800216.46038.35

(Abstracted from Am J Obstet Gynecol 2021; doi: 10.1016/j.ajog.2021.06.067). Endometriosis, defined as the presence of extrauterine endometrial tissue, often has serious symptoms that significantly impact the lives of those affected and is …

observational 2020
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2020.01.016

BACKGROUND: Adenomyosis symptoms are disabling. Population-based data on incidence and prevalence of adenomyosis are lacking that could guide future evidence-based treatments and clinical management. OBJECTIVE: To evaluate the incidence, 1…

2020
·doi:10.1016/j.fertnstert.2020.08.172
other 2019
EGEMS (Washington, DC) ·doi:10.5334/egems.264

INTRODUCTION: Uterine fibroids are the most common benign tumors of the uterus and are associated with considerable morbidity. Diagnosis codes have been used to identify fibroid cases, but their accuracy, especially for incident cases, is u…

review 2017
Obstetrics and gynecology ·doi:10.1097/aog.0000000000001809

Women are at a higher risk for depression than are men, and this risk is especially pronounced at specific reproductive periods of vulnerability: adolescence, pregnancy, postpartum, and the menopausal transition. Obstetrician-gynecologists …

rct 2016
Journal of the National Cancer Institute ·doi:10.1093/jnci/djv350

BACKGROUND: While progestin addition to estrogen mitigates endometrial cancer risk, the magnitude of the effect on incidence, specific endometrial cancer histologies, and endometrial cancer mortality remains unsettled. These issues were ass…